Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05012605 · ClinicalTrials.gov registry record
The SLEEPR Study: SLEep Effects on Post-stroke Rehabilitation
A clinical trial of Stroke and Rehabilitation, sponsored by State University of New York - Upstate Medical University.
- Recruiting
- Registry status
- 200
- Enrollment target
- 6
- Study locations
NCT05012605: Recruiting study of Stroke and Rehabilitation, sponsored by State University of New York - Upstate Medical University.
NCT05012605 is a study of Stroke and Rehabilitation that is actively recruiting participants, run by State University of New York - Upstate Medical University. The registered enrollment target is 200 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (98% lower). The trial reports 6 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05012605, a study of Stroke and Rehabilitation, is actively recruiting participants, sponsored by State University of New York - Upstate Medical University.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 6
- Study locations
Study Summary
Sleep is critical for health and quality of life; however, little is known about the prevalence or impact of non obstructive sleep apnea (non-OSA) sleep disorders in people with stroke. The proposed study aims to characterize the proportion of people with stroke that have non-OSA sleep disorders and their impact on recovery of activities of daily living, functional mobility, and participation along the continuum of recovery in people with stroke.
Conditions Studied
Interventions
- OTHER Observation
Study Locations (6)
New York
- Institute for Human Performance - Upstate Rehabilitation at IHP - Syracuse
- Upstate University Hospital - Syracuse
- Upstate Community Hospital - Syracuse
Georgia
- Emory University - Atlanta
Kansas
- KU Medical Center, The University of Kansas - Kansas City
Pennsylvania
- Good Shepherd Rehabilitation Network - Allentown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2021-03-25 |
| Est. Completion | 2025-06-30 |
What NCT05012605 shows while recruiting
NCT05012605 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (98% lower).
The record links to 4 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Observation is the first listed.
NCT05012605 lists 6 locations in 4 states (New York, Georgia, Kansas).
Frequently Asked Questions
What is clinical trial NCT05012605 about?
NCT05012605 is a clinical study titled "The SLEEPR Study: SLEep Effects on Post-stroke Rehabilitation". Sleep is critical for health and quality of life; however, little is known about the prevalence or impact of non obstructive sleep apnea (non-OSA) sleep disorders in people with stroke. The proposed study aims to characterize the proportion of people with stroke that have non-OSA sleep disorders and...
What is the current status of trial NCT05012605?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2021-03-25. Estimated completion is 2025-06-30.
What conditions does trial NCT05012605 study?
This clinical trial studies the following conditions: Stroke, Rehabilitation, Sleep Wake Disorders, Recovery of Function.
What interventions are being tested in trial NCT05012605?
The interventions under investigation include: Observation (OTHER).
Who is sponsoring clinical trial NCT05012605?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05012605 being conducted?
This trial has 6 study locations across Georgia, Kansas, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05012605's enrollment target sits among peer trials
200 96th of 454 higher than 355 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
RECRUITING
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI